USGI Medical, Inc.

USGI Medical, Inc. specializes in innovative endoluminal technologies that enhance minimally invasive surgical procedures, focusing on improving patient outcomes through advanced medical devices. Founded in 2001, USGI Medical, Inc. is located in San Clemente, California, US.

The company is dedicated to developing solutions for minimally invasive surgeries. In January 2015, USGI Medical raised USD 19. 5 mn in venture funding from Alta Partners, GE Capital, and Healthcare Financial Services, which contributed to their goal of advancing surgical technologies. The company has executed a total of seven deals since its inception.

USGI Medical focuses on revolutionizing the surgical landscape through its innovative endoluminal technologies designed for minimally invasive procedures. The company’s core offerings include three primary product lines: TransPort, Endoluminal Suturing, and Snowshoe Suture Anchors. TransPort provides a stable platform for flexible endoscopic procedures, featuring four working channels and the ability to steer in four directions, thus facilitating precision in various gastrointestinal treatments. Endoluminal Suturing is designed to approximate soft tissue without incisions, allowing for serosa-to-serosa tissue fusion with exceptional durability.

Snowshoe Suture Anchors are expandable soft tissue anchors used in full-thickness plications, providing user-controlled cinching to enhance surgical outcomes. These products primarily target healthcare providers and institutions in North America, Europe, and select markets in Asia, addressing critical needs in gastroenterology by offering incisionless solutions that improve patient recovery times and reduce surgical risks. USGI Medical generates revenue through direct sales of its medical devices to healthcare facilities, primarily hospitals and surgical centers specializing in gastroenterology. The company employs a business-to-business (B2B) transaction structure, partnering with healthcare providers to integrate its technologies into clinical practice.

Revenue transactions occur on a per-unit basis, reflecting the purchase of specific products such as the TransPort system or the Snowshoe Suture Anchors, which are utilized during surgical procedures. These products are strategically priced to align with the clinical value they provide, ensuring competitive positioning within the medical device market. Revenue is further enhanced through strategic partnerships with healthcare providers, allowing for collaborative development and distribution of their innovative solutions. USGI Medical plans to leverage the USD 19.

5 mn raised in January 2015 to support the development of new products and expand into new geographic markets. Specific strategies include designing additional endoluminal devices aimed at enhancing surgical efficiency, with potential launches anticipated within the next two years. The company is targeting expansion into Asia and additional European countries by 2025, aiming to reach broader healthcare networks and address rising demands for minimally invasive surgical solutions.